{"title":"[精神病患者对抗精神病药的早期反应对后续治疗的预后价值]。","authors":"H J Möller, W Kissling, D von Zerssen","doi":"10.1055/s-2007-1017447","DOIUrl":null,"url":null,"abstract":"<p><p>There is some evidence that the early response of schizophrenic patients to neuroleptic treatment is of prognostic value for the subsequent course of treatment. This hypothesis was confirmed in a prospective study. It was demonstrated that already the therapeutic effect on the first day of treatment is of prognostic value, especially with a standardized drug regimen.</p>","PeriodicalId":19840,"journal":{"name":"Pharmacopsychiatria","volume":"16 2","pages":"46-9"},"PeriodicalIF":0.0000,"publicationDate":"1983-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2007-1017447","citationCount":"20","resultStr":"{\"title\":\"[Prognostic value of the early response of psychiatric patients to neuroleptics for the subsequent course of treatment].\",\"authors\":\"H J Möller, W Kissling, D von Zerssen\",\"doi\":\"10.1055/s-2007-1017447\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There is some evidence that the early response of schizophrenic patients to neuroleptic treatment is of prognostic value for the subsequent course of treatment. This hypothesis was confirmed in a prospective study. It was demonstrated that already the therapeutic effect on the first day of treatment is of prognostic value, especially with a standardized drug regimen.</p>\",\"PeriodicalId\":19840,\"journal\":{\"name\":\"Pharmacopsychiatria\",\"volume\":\"16 2\",\"pages\":\"46-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1983-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1055/s-2007-1017447\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacopsychiatria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-2007-1017447\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacopsychiatria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2007-1017447","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Prognostic value of the early response of psychiatric patients to neuroleptics for the subsequent course of treatment].
There is some evidence that the early response of schizophrenic patients to neuroleptic treatment is of prognostic value for the subsequent course of treatment. This hypothesis was confirmed in a prospective study. It was demonstrated that already the therapeutic effect on the first day of treatment is of prognostic value, especially with a standardized drug regimen.